Stories about Opioid

Subscribe to Opioid

29.09.2021 – 10:02

Grünenthal Group
First participants enrolled in Clinical Trial with Nociceptin/Orphanin peptide receptor (NOP) agonist

Aachen (ots) - Today, Grünenthal announced that the first participants have been enrolled in a randomised, placebo- and active-controlled clinical trial for its peripherally restricted Nociceptin/Orphanin FQ peptide receptor (NOP) agonist. The compound is being developed to provide a non-opioid therapy option that ...

more
27.04.2021 – 10:00

Medasense Biometrics Ltd
Pain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs

Ramat Gan, Israel (ots/PRNewswire) - A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with NOL® technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Extrapolating the results of this study, an economic analysis has shown that by facilitating reduced postoperative pain, using ...

more
07.04.2021 – 10:56

Grünenthal Group
Grünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks

Aachen, Germany (ots) - - Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry - Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies ...

more
16.12.2020 – 10:00

Grünenthal Group
Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development

Aachen (ots) - Grünenthal announced today that the first participants have been enrolled in a Phase I trial of a peripherally restricted Nociceptin/orphanin peptide receptor (NOP) agonist, an oral investigational medicine with a unique mechanism of action for the treatment of chronic peripheral neuropathic pain. The Phase I trial will include 76 healthy participants. ...

more
29.09.2020 – 09:30

Medasense Biometrics Ltd
New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery

Ramat Gan, Israel (ots/PRNewswire) - A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the study demonstrated that ...

more
18.12.2019 – 14:07

Grünenthal Group
Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin) 8% Patch for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

Morristown, N.J. (ots) - · PDUFA date set for July 19, 2020 · If approved, QUTENZA would be the first topical treatment with a TRPV1 agonist indicated for the treatment of neuropathic pain associated with diabetic peripheral neuropathy. Averitas Pharma, Inc., a subsidiary of GRT US Holding, Inc. and member of the ...

more

1